The 36-month beta value for ALHC is at 1.50. Analysts have varying views on the stock, with 8 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for ALHC is 92.47M, and currently, shorts hold a 10.03% of that float. The average trading volume for ALHC on February 05, 2025 was 2.00M shares.
ALHC) stock’s latest price update
Alignment Healthcare Inc (NASDAQ: ALHC)’s stock price has increased by 0.59 compared to its previous closing price of 15.37. However, the company has seen a 1.58% increase in its stock price over the last five trading sessions. seekingalpha.com reported 2025-01-16 that Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.
ALHC’s Market Performance
ALHC’s stock has risen by 1.58% in the past week, with a monthly rise of 33.74% and a quarterly rise of 24.68%. The volatility ratio for the week is 3.42% while the volatility levels for the last 30 days are 4.87% for Alignment Healthcare Inc The simple moving average for the last 20 days is 9.22% for ALHC stock, with a simple moving average of 53.91% for the last 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at 22.59% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.28% of loss for the given period.
Volatility was left at 4.87%, however, over the last 30 days, the volatility rate increased by 3.42%, as shares surge +32.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +39.40% upper at present.
During the last 5 trading sessions, ALHC rose by +1.58%, which changed the moving average for the period of 200-days by +212.32% in comparison to the 20-day moving average, which settled at $14.15. In addition, Alignment Healthcare Inc saw 37.42% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from Kardes Hakan, who sale 14,500 shares at the price of $14.98 back on Jan 24 ’25. After this action, Kardes Hakan now owns 295,444 shares of Alignment Healthcare Inc, valued at $217,277 using the latest closing price.
Kardes Hakan, the Chief Experience Officer of Alignment Healthcare Inc, sale 10,500 shares at $14.99 during a trade that took place back on Jan 21 ’25, which means that Kardes Hakan is holding 309,944 shares at $157,370 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.65. The debt to equity ratio resting at 1.92. The interest coverage ratio of the stock is -5.14.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 1.15. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
In conclusion, Alignment Healthcare Inc (ALHC) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
